Unisol 100 mg/ml Oral Solution for use in drinking water for chickens and turkeys

Nchi: Ayalandi

Lugha: Kiingereza

Chanzo: HPRA (Health Products Regulatory Authority)

Viambatanisho vya kazi:

Enrofloxacin

Inapatikana kutoka:

Vetpharma Animal Health, S.L.

ATC kanuni:

QJ01MA90

INN (Jina la Kimataifa):

Enrofloxacin

Kipimo:

100 milligram(s)/millilitre

Dawa fomu:

Solution for use in drinking water

Dawa ya aina:

POM: Prescription Only Medicine as defined in relevant national legislation

Kundi la matibabu:

Chickens, Turkeys

Eneo la matibabu:

enrofloxacin

Matibabu dalili:

Antibacterial

Idhini hali ya:

Authorised

Idhini ya tarehe:

2010-02-26

Tabia za bidhaa

Health Products Regulatory Authority
19 July 2018
CRN000YNC
Page 1 of 6
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Unisol 100 mg/ml Oral Solution for use in drinking water for chickens
and turkeys.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
ACTIVE SUBSTANCE:
Enrofloxacin..........................................................
100.0 mg
EXCIPIENTS:
Benzyl Alcohol (E 1519)......................................... 14.0
mg
F
or a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Oral Solution for use in drinking water.An aqueous, clear, yellowish
solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Chickens and Turkeys.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment of infections caused by the following bacteria susceptible
to enrofloxacin:
CHICKENS
_Mycoplasma gallisepticum,_
_Mycoplasma synoviae,_
_Avibacterium paragallinarum,_
_Pasteurella multocida._
TURKEYS
_Mycoplasma gallisepticum,_
_Mycoplasma synoviae,_
_Pasteurella multocida._
Enrofloxacin should be used where clinical experience, supported where
possible by
sensitivity testing of the causal organism, indicates enrofloxacin as
the active substance of
choice.
Health Products Regulatory Authority
19 July 2018
CRN000YNC
Page 2 of 6
4.3 CONTRAINDICATIONS
Do not use for prophylaxis.
Do not use when resistance / cross-resistance to (fluoro)quinolones is
known to occur in the
flock intended for treatment. Do not use in cases of known
hypersensitivity to the active
substance, other (fluoro)quinolones or to any of the excipients.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Treatment of _Mycoplasma _spp. infections may not eradicate the
organism.
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Before use, header tanks should be emptied, thoroughly cleaned and
then filled with a
known volume of clean water before adding the required amount of
product. The resulting
mixture should be stirred.
Before use, header tanks should be inspected at regular intervals for